MXPA05004108A - Composicion para reducir la ingesta calorica. - Google Patents

Composicion para reducir la ingesta calorica.

Info

Publication number
MXPA05004108A
MXPA05004108A MXPA05004108A MXPA05004108A MXPA05004108A MX PA05004108 A MXPA05004108 A MX PA05004108A MX PA05004108 A MXPA05004108 A MX PA05004108A MX PA05004108 A MXPA05004108 A MX PA05004108A MX PA05004108 A MXPA05004108 A MX PA05004108A
Authority
MX
Mexico
Prior art keywords
caloric intake
cholecystokinin
release
meal
composition
Prior art date
Application number
MXPA05004108A
Other languages
English (en)
Inventor
Portman Robert
Original Assignee
Pacifichealth Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacifichealth Lab Inc filed Critical Pacifichealth Lab Inc
Publication of MXPA05004108A publication Critical patent/MXPA05004108A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describe una composicion para reducir la ingesta calorica estimulando la liberacion de colecistocinina tras la ingestion, que contiene glucomacropeptido y los excipientes convenientes para la ingestion en ausencia considerable de otros agentes conocidos para estimular la liberacion de la colecistocinina despues de la ingestion. Las composiciones pueden ademas contener otro agente que reduzca la ingesta calorica por un modo de accion diferente a la estimulacion de la liberacion de colecistocinina. La invencion ademas comprende un metodo para lograr una reduccion de la ingesta calorica haciendo que un individuo en necesidad de esta ingiera una cantidad eficaz de las composiciones descritas durante el consumo de alimentos o hasta aproximadamente 10 minutos antes del consumo de los alimentos. Una cantidad eficaz de las composiciones que ha de ser consumidas antes o con el alimento por lo regular proporcionara desde aproximadamente 0.2 hasta aproximadamente 3 gramos del glucomacropeptido puro.
MXPA05004108A 2002-10-18 2003-10-17 Composicion para reducir la ingesta calorica. MXPA05004108A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/274,071 US20040077530A1 (en) 2002-10-18 2002-10-18 Composition for reducing caloric intake
PCT/US2003/033021 WO2004034813A2 (en) 2002-10-18 2003-10-17 Composition for reducing caloric intake

Publications (1)

Publication Number Publication Date
MXPA05004108A true MXPA05004108A (es) 2005-10-05

Family

ID=32092954

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05004108A MXPA05004108A (es) 2002-10-18 2003-10-17 Composicion para reducir la ingesta calorica.

Country Status (9)

Country Link
US (1) US20040077530A1 (es)
EP (1) EP1551442A2 (es)
JP (1) JP2006503099A (es)
CN (1) CN1723033A (es)
AU (1) AU2003301261A1 (es)
BR (1) BR0315495A (es)
CA (1) CA2502794A1 (es)
MX (1) MXPA05004108A (es)
WO (1) WO2004034813A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9307991B2 (en) 2002-08-22 2016-04-12 Ams Research, Llc Anastomosis device and related methods
US20060013903A1 (en) * 2004-07-16 2006-01-19 Timothy Romero Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss
US20070172474A1 (en) * 2004-04-02 2007-07-26 University Of Tennessee Research Foundiation Dairy components effective for fat loss
US7968138B2 (en) 2004-07-23 2011-06-28 Arnold Nerenberg Food sweetener
AU2006235407B2 (en) * 2005-04-11 2011-02-24 University Of Tennessee Research Foundation Stable dairy components effective for fat loss
WO2007037413A1 (ja) 2005-09-30 2007-04-05 Morinaga Milk Industry Co., Ltd. グルカゴン様ペプチド－1分泌促進剤、グルカゴン様ペプチド－1分泌促進用飲食品、食後血糖値上昇抑制剤および食後血糖値上昇抑制用飲食品
WO2009018166A1 (en) * 2007-07-27 2009-02-05 Nutritional Network, Inc. Exercise performance and recovery formulations
WO2009112036A2 (en) * 2008-03-12 2009-09-17 Arla Foods Amba Whey protein beverages having reduced astringency
US20110045160A1 (en) * 2008-04-30 2011-02-24 Nestec S.A. Satiety inducing food composition
CN102481338A (zh) * 2009-06-12 2012-05-30 威斯康星校友研究基金会 用于苯丙酮尿症和其他代谢疾病的营养控制的糖巨肽药用食物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
JPH0699321B2 (ja) * 1990-01-22 1994-12-07 不二製油株式会社 食欲抑制剤及びこれを含有する食品
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
US5670201A (en) * 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
FR2758143B1 (fr) * 1997-01-07 1999-02-19 Laphal Laboratoire De Pharmaco Inhibiteurs specifiques de la lipase pancreatique et leurs applications
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5932561A (en) * 1997-10-24 1999-08-03 Rexall Sundown, Inc. Dietary composition with lipid binding properties for weight management and serum lipid reduction
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6429190B1 (en) * 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
US6420350B1 (en) * 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product
US6797290B2 (en) * 2001-09-17 2004-09-28 Mcneil-Ppc, Inc. Compositions for appetite control and related methods

Also Published As

Publication number Publication date
US20040077530A1 (en) 2004-04-22
JP2006503099A (ja) 2006-01-26
WO2004034813A2 (en) 2004-04-29
BR0315495A (pt) 2005-08-23
EP1551442A2 (en) 2005-07-13
AU2003301261A1 (en) 2004-05-04
CA2502794A1 (en) 2004-04-29
CN1723033A (zh) 2006-01-18
WO2004034813A3 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2002256093A1 (en) Bulking agents as satiety agents
WO2002047614A3 (en) Nutritional composition for improving the efficacy of a lipase inhibitor
TWI265808B (en) Valdecoxib compositions
MX2007003078A (es) Compuestos de imidazoquinolina.
MXPA02012763A (es) Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus.
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
BG103800A (en) Method and composition for the treatment of apnoea
AU4451101A (en) Method and compositions for preventing hormone induced adverse effects
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
YU30700A (sh) Kombinacija inhibitora aldozo reduktaze i inhibitora glikogen fosforilaze
AR018924A1 (es) Composicion para la prevencion y/o tratamiento de osteoporosis y alteraciones debidas al sindrome de menopausia
MXPA05004108A (es) Composicion para reducir la ingesta calorica.
WO2002043719A3 (en) Composition and method for treating snoring
TW200740427A (en) Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate
CA2451725A1 (en) Therapeutic combinations for the treatment of hormone deficiencies
MXPA02007117A (es) Composiciones para suministrar un antagonista de cortisol..
GB9517443D0 (en) Increasing creatine and glycogen concentration in muscle
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
NZ577390A (en) Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
AU3109502A (en) Method and composition for the treatment of diabetic neuropathy
MXPA04002565A (es) Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion.
WO2004017917A3 (en) Method for the prevention and/or treatment of atherosclerosis
PL372096A1 (en) Method of treating sexual dysfunctions with delta opioid receptor agonist compounds